ABVD is a chemotherapy regimen for treatment of Hodgkin's lymphoma, consisting of concurrent treatment with adriamycin, bleomycin, vinblastine and dacarbazine. Patients typically receive treatment in cycles of 4 weeks, with two treatments in each cycle, two weeks apart. All drugs are administered intravenously.

Cancer treatments